Pharmaceutical companies are asking the federal government to help fund the development of new medicines they say they cannot afford to make themselves, but are critical to saving lives from antibiotic resistance.

Drugmaking giants Pfizer, GSK and others have called on Labor to introduce a subscription-style model where it would pay them a fixed fee of up to $15 million a year per drug.